Curriculum Vitae for Ji-Hyun Lee
Date: August 20, 2009
Current Position: Associate Member
Biostatistics Division
Moffitt Cancer Center;
12902 Magnolia Dr.
Tampa, FL 33612
Tel: (813)745-6336; Fax: (813)745-6525
Email: ji-hyun.lee@moffitt.org; Web: http://personal.health.usf.edu/jlee2/
Current Academic
Appointments: Associate Professor
University of South Florida College of Medicine
Department of Oncologic Sciences
12901 Bruce B. Downs Blvd.
Education:
2000 – 2003 DrPH in Biostatistics, The University of North Carolina at Chapel Hill (UNC-CH)
1998 – 2000 M.S. in Biostatistics, The University of North Carolina at Chapel Hill (UNC-CH)
1989 – 1991 M.A. in Sociology, Dong-A University, Pusan, South Korea
Academic Appointments and Employment:
|
7/08 – present
|
Associate Member (tenured)/ Assistant Member (9/03 – 6/08), Biostatistics Division, H. Lee Moffitt Cancer Center & Research Institute (Moffitt Cancer Center); Associate Professor of Oncologic Sciences, University of South Florida College of Medicine
|
|
12/04 – present |
Faculty Member, Cancer Biology PhD Program at Moffitt Cancer Center, University of South Florida
|
|
7/08 – present |
Associate Professor/ Assistant Professor (9/06 – 06/08), Department of Mathematics and Statistics, University of South Florida College of Arts & Sciences |
|
12/04 – present
|
Associate Professor/ Assistant Professor (12/04 – 06/08), Department of Epidemiology and Biostatistics, University of South Florida College of Public Health |
|
12/03 – present |
Member in Residence, Moffitt Cancer Center
|
|
8/00 – 7/03 |
Statistical Research Assistant, Lineberger Comprehensive Cancer Center, School of Medicine, UNC-CH |
|
7/02 – 9/02 |
Statistical Research Assistant, Statistical Research and Applications Branch, National Cancer Institute/NIH, MD, USA |
|
8/98 – 8/00 |
Statistical Research Assistant & Consulting, Cystic Fibrosis Center, School of Medicine, UNC-CH
|
|
1/98 – 8/98 |
SAS programmer, Collaborative Studies Coordination Center at the Department of Biostatistics, UNC-CH |
Languages Spoken: English and Korean
Teaching Experience
University and In-Class Courses
Fall 06 – Present Course Instructor Design and Conduct of Clinical Trials (PHC 6017; Graduate Course), Department of Epidemiology and Biostatistics, College of Public Health, University of South Florida, Tampa, FL
Spring 07 – Present Course Guest Instructor Design and Conduct of Clinical Trials for Drugs and Therapies (GMS 7930: Graduate Course), Department of Molecular Medicine, College of Medicine, University of South Florida, Tampa, FL
Spring 08 – Present Course Coordinator/Instructor, Biostatistics 101 for Cancer Researchers, Moffitt Cancer Center, Tampa, FL
April 2008 Course Coordinator/Instructor, Biostatistics Workshop, Ponce School of Medicine, Puerto Rico (U57 GRANT support)
Honors and Awards
4/2008 Recognition for Outstanding Faculty Performance, Division of Population Sciences, Moffitt Cancer Center, 2008 7/2006 R03 Grant Award, NIH/NIBIB 4/2005 Travel Grant Award for 55th International Statistical Institute Meeting at Sydney, Australia, The American Statistical Association (ASA).
5/2004 New Researcher Grant Award for Junior Faculty, University of South Florida 9/1999 Special Commendation for the Highest Scores on M.S. Theory Part Qualifying Exams, UNC-CH
Research Support
| Current Active Funded-Grants: | |
| [1] |
Account #: RRSGPB-05-242-01-CPPB (Brandon-PI) (Lee– Co-Investigator) Dates: 1/01/2006 – 12/31/2008 Source: American Cancer Society Title: Translating Basic Learning Research into Enhanced Smoking Cessation % Effort: 5% Total Direct Costs: $810,771 Total Amount of Award: $945,000
|
| [2] |
Account #: R01 5 R01 CA098803 (Giuliano-PI) (Lee– Co-Investigator) Dates: 09/27/2004 - 8/31/2009 Source: NIH Title: Natural History of HPV Infection in Men: The HIM Study % Effort: 5% Total Direct Costs: $736,269 Total Amount of Award: $1,018,231
|
| [3] |
Account #: R01 CA081310-04 (Giuliano-PI) (Lee– Co-Investigator) Dates: 09/27/2004 - 11/30/2008 Source: NIH Title: Effect of Oxidant Load on HPV Persistence and CIN (SIL) % Effort: 5% Total Direct Costs: $367,322 Total Amount of Award: $513,947
|
| [4] |
Account #: R01 CA111914-01 (Pal-PI) (Lee– Co-Investigator) Dates: 04/29/2005 - 2/28/2010 Source: NCI Title: Ovarian cancer and mismatch repair % Effort: 5% Total Direct Costs: $1,435,870 Total Amount of Award: $1,852,422
|
| [5] |
Account #: U01 CA114627 (Meade-PI) (Lee– Co-Investigator) Dates: 05/25/2005 - 4/30/2010 Source: NCI/NIH Title: Tampa Bay Community Cancer Network (TB-CCN): A model for reducing health disparities % Effort: 5% Total Direct Costs: $1,231,483 Total Amount of Award: $2,007,316
|
| [6] |
Account #: U01 CA117281 (Roetzheim-PI) (Lee– Co-Investigator) Dates: 9/29/2005 - 8/31/2010 Source: NIH/NCI Title: Patient Navigator Program % Effort: 3% Total Direct Costs: $1,168,269 Total Amount of Award: $2,580,729
|
| [7] |
Account #: R01 AA011157 (Drobes-PI) (Lee– Co-Investigator) Dates: 1/10/2006 - 11/30/2010 Source: NIH Title: Drug/Cue Interactions in Alcohol-Tobacco Comorbidity % Effort: 5% Total Direct Costs: $1,012,500 Total Amount of Award: $1,624,186
|
| [8] |
Account #: MRSG-06-093-01-CPPB (Vadaparampil-PI) (Lee– Co-Investigator) Dates: 1/01/2006 - 12/31/2010 Source: ACS Title: Impact of Genetic Testing on Cancer Patients % Effort: 5% Total Direct Costs: $649,520 Total Amount of Award: $706,000
|
| [9] |
Account #: R01 CA103965 01A2 (Roetzheim-PI) (Lee– Sub-Contractor PI) Dates: 4/22/2005 - 2/29/2010 Source: NCI/NIH Title: Sun Protection for Florida¨s Children % Effort: 7% Total Direct Costs: $220,063 Total Amount of Award: $315,181
|
| [10] |
Account #:1R01 CA123346-01 (Daley and Guiliano-PI) (Lee– Co-Investigator) Dates: 8/1/2006 - 7/31/2011 Source: NCI Title: Cognitive and Emotional Responses to HPV Diagnosis in Men % Effort: Year 1-4: 5%; Year 5: 15% Total Direct Costs: $341,706 Total Amount of Award: $418,673
|
| [11] |
Account #: 60-14985-99-01 (Quinn-PI) (Lee– Co-Investigator) Dates: 01/02/2007 – 12/30/2010 Source: ASC Title: Physician Barriers to Discussing Fertility Preservation with Cancer Patients % Effort: 6.5% Total Direct Costs: $464,635 Total Amount of Award: $735,746
|
| [12] |
Account #: 84-15065-99-01 (Jacobsen-PI) (Lee– Co-Investigator) Dates: 01/01/2007 – 12/31/2010 Source: Pfizer, Inc. Title: Total Cancer Care (TCC)-Quality of Care Projects % Effort: 10% Total Direct Costs: $8,857,132 Total Amount of Award: $10,293,528
|
| [13] |
Account #: 11-15474-9901(Vadaparamil-PI) (Lee– Co-Investigator) Dates: 7/02/08 – 6/30/12 Source: National Institute of Allergy and Infectious Disease/NIH Title: Recommendation of HPV Vaccination Among U.S. Physicians % Effort: 7% Total Direct Costs: $1,277,541 Total Amount of Award: $1,878,382
|
| [14] |
Account #: 1 R01 CA137357-01 (Brandon, PI) (Lee– Co-Investigator) Date: 01/01/09 – 11/30/12 Source: NCI Title: Relapse-Prevention Booklets as Adjunct to a Tobacco Quitline % Effort: 7.5% Total Direct Costs: $365,535 year 1 direct costs Total Amount of Award:
|
| [15] |
Account #: RSGHP-08-141-01-CPHPS (Roetzheim, PI)( Lee -Sub-Contractor PI) Dates: 7/01/08 – 6/30/11 Source: ACS Title: Primary Care and cancer Outcomes Among Medicare beneficiaries % Effort: 10% Total Direct Costs: $335,492 Total Amount of Award: $470,000
|
| [16] |
Account #: R01 CA CA134347-01A1 (Brandon-PI) (Lee– Co-Investigator) Dates: 05/11/2009 – 3/31/2014 Source: NCI Title: Extended Self-Help for Smoking Cessation % Effort: 5% Total Direct Costs: $ 70,000 proposed year 1 direct costs Total Amount of Award: $571,835 |
| Pending Grants: | |
|
[1] |
Application ID: KG091051 (Pal-PI) (Lee– Co-Investigator) Dates: 2009-2014 Source: Komen for the Cure Title: Breast Cancer in Blacks: The ASPIRE (Advancing the Study of Progression, Inheritance, Risks and Etiology) Project % Effort: 30% Role in Study: Co-Investigator Total Direct Costs: $6,991,522 Total Amount of Award: $7,400,459 Date Submitted: 12/04/08 |
| Completed Grants: | |
|
[1] |
Account #: 1R03 EB0056401 (Lee– Primary Investigator) Dates: 08/01/2006 – 6/31/2008 Source: National Institute of Biomedical Imaging and Bioengineering/NIH Title: An Exact Test for Overdispersion in Screening Mammography Assessments % Effort: 25% for 1st year; 1% for 2nd year Total Direct Costs: $50,000 Total Amount of Award: $81,500
|
|
[2] |
Account #: USF01 18300 (Lee-PI) Dates: 5/1/04 – 4/30/05 Source: USF Title: New Research % Effort: 5% Total Direct Costs: $5,400
|
|
[3] |
Account # : 10-14057-04-04(Mede/Gwede- PI/Co-PI) (Lee– Co-Investigator) Dates: 8/1/07 – 7/31/08 Source: NIH/NCI Title: Colorectal Cancer in Ethnic Subgroups of U.S. Blacks: Exploring Diversity % Effort: 3% Total Direct Costs: $50,000 Total Amount of Award: $81,326
|
|
[4] |
Account #:R21 CA112913 (Munster-PI) (Lee– Co-Investigator) Dates: 9/29/2006 - 1/31/2008 Source: NCI/NIH Title: Potentiation of Topo Inhibitors by HDAC, SAHA % Effort: 5% Total Direct Costs: $279,882 Total Amount of Award: $426,586
|
|
[5] |
Account # 1R21 CA101324 (Gabrilovich-PI) (Lee–Co-Investigator) Dates: 7/15/04 – 6/30/06 Source: NIH/NCI Title: Effect on Myeloid Cell Differentiation in Cancer % Effort: 5% Total Direct Costs: $369,000 Total Amount of Award: $601,470
|
|
[6] |
Account # R21 CA 105875 (Munster-PI) (Lee–Co-Investigator) Dates: 9/30/04 - 8/31/06 Source: NCI/NIH Title: Potentiation of Topo Inhibitors by HDAC Inhibitors % Effort: 5% Total Direct Costs: $315,230 Total Amount of Award: $504,418
|
|
[7] |
Account #: R01 CA 94256-02 (Brandon-PI) (Lee– Co-Investigator) Dates: 08/01/2002 – 7/31/2008 Source: NCI Title: Preventing smoking relapse during pregnancy and beyond % Effort: 5% Total Direct Costs: $ 607,245 Total Amount of Award: $1,404,034
|
|
[8] |
Account #:1 R01 CA11824709-01A1 (Rollison-PI) (Lee– Co-Investigator) Dates: 9/01/2006 - 7/31/2009 Source: NIH/NCI Title: Nested Case-Control Study of JC Virus Infection and Incident Colorectal Cancer % Effort: 5% Total Direct Costs: $708,796 Total Amount of Award: $923,953
|
Thesis, MS in Biostatistics, UNC-CH
ARIC Intra-Individual
Variability Study of Retinal Photography Measurements.
Advisor: David Couper, Ph.D.
Dissertation, DrPH in Biostatistics, UNC-CH
Practical Issues Arising
in Clustered Data: Modified GEE and Goodness-Of-Fit Test, Overdispersion,
and Change-point Models.
Advisor: Bahjat F. Qaqish, Ph.D.
Service
Internal Committee Service:
University of South Florida
2007 Search Committee Member for Full/Assistant Professors, Department of Mathematics and Statistics, College of Art and Science, USF
2005 – 2007 USF Internal Award Grants (as a reviewer and panelist)
Moffitt Cancer Center
2008 – Present APT committee member, Cancer Prevention & Control Division
2007 – Present Reviewer, Department of Interdisciplinary Oncology Research Account Fund Grants
Review Committee
2006 – Present Committee Member, Grand Rounds in Population Sciences (GRIPS);
Cancer Control Research Interest Group Planning Meeting
2006 – 2007 Member, Protocol Monitoring Committee (PMC)
2005 Reviewer, American Cancer Society Institutional Research Grants
2005 – Present Committee Member, Total Cancer Care (TCC) Quality Improvement Workgroup
2004 – Present Member, Scientific Protocol Review Committee (SRC)
2004 – 2005 Reviewer Aging NCI Institutional Research Grants, Moffitt
Federal Government Public Advisory Committee Service
|
10/2006 – Present |
Member, Special Emphasis Panel, The Discovery and Development Program Project (P01), NCI/NIH (at least 2 site meetings per year) |
|
2/2006 |
Ad Hoc Member, Molecular Therapeutics Program Project (P01) Cluster Applications, NCI/NIH |
ENAR (Eastern North American Region) Service
|
3/2007 |
Organizer and Chair, Scientific Program for Group Randomized Trials: Introductory Lecture Session, International Biometric Society Meeting, Atlanta, GA. * ENAR is an annual meeting hosted by the International Biometric Society, USA. |
|
3/2008 |
Chair, Joint Modeling Session, International Biometric Society Meeting, ENAR, Virginia, VA. |
Editorial Board Service
|
2005 – Present |
Statistical Advisor for Public Library of Science (PLoS) Clinical Trials and PLoS One: Europe |
|
2007 – Present |
Statistical Editor for Medical Problems of Performing Artists (MPPA) |
|
2008 – Present |
Peer Review Panelist for The Journal of Midwifery and Women's Health (JMWH) |
Referee for
Statistics in Medicine/ Journal of Clinical Oncology/ Journal of Medical & Pediatric Oncology/Journal of EBIM/Addictive Behaviors/PLoS Clinical Trials/Annals of Surgical Oncology
Public and Community Service:
2004 – Present Musician for Ultrasounds USF Orchestra, Health Science Center, USF
Professional Association Memberships:
|
American Statistical Association (ASA) |
|
The International Biometric Society/Eastern North American Region (ENAR) |
|
Society for Clinical Trials |
Peer-Reviewed Publications
[2] Vadaparampil, S. T., Quinn, G., Lee, J.-H., Malo, T., Zhao, X., Miree, C., and Brzosowica, J. (2009). Satisfaction with Physician Recommendation for and Information about Genetic Counseling among Recently Diagnosed Breast Cancer Patients. (Submitted).
[3] Malafa, M., Corman, M., Shibata, D., Siegel, E.M., Lee, J.-H., and Jacobsen, P.B. (2009). The Florida Initiative for Quality Cancer Care: A Regional Project to Measure and Improve Cancer Care. (Submitted).
[4] Lee, J.-H., Miladinovic, B., and Schell, J. M. (2009). Analysis of Two Group Comparisons: A Practical Guide. MPPA (Accepted)
[5] Quinn, G., Vadaparampil, S.T., Lee, J.-H., Jacobsen, P.B., Bepler, G., Lancaster, J., Keefe, D.L., Albrecht, T., and Moffitt Fertility Preservation Group (2009). Physician referral for fertility preservation with oncology patients: a national study. Journal of Clinic Oncology (In press).
[6] Gwede, C.K., William, C. M., Thomas, K.B., Tarver, W.L., Quinn G.P., Vadaparampil, S.T., Kim, J., Lee, J.-H., Meade, C.D., and Tampa Bay Community Cancer Network (TBCCN) (2009). Exploring Disparities and Variability in Perceptions and Self-Reported Colorectal Cancer Screening Among Three Ethnic Subgroups of U.S. Blacks. Oncology Nursing Forum (Accepted).
[7] Kim, J., Pal, T., and Lee, J.-H.* (2009). The graphical evaluation on reproducibility between two observers using concordance correlation coefficient. (Submitted)
[8] Lee, J.-H., Schell, M. J., and Roetzheim, R. (2009). Analysis of Group Randomized Trials with Multiple Binary Endpoints and Small Number of Groups. PLoS One 4 (10).
[9] Munster, P., Marchion, D., Thomas, S., Egorin, M., Minton, S., Springett, G., Lee, J.-H., Simon, G., Chiappori, A., Sullivan, D., and Daud, A. (2009). Phase I trial of a sequence-specific combination of the HDACi, vorinostat (SAHA) followed by doxorubicin in advanced solid tumor malignancies. (Submitted).
[10] Hunter, S., Wells, K. J., Jacobsen, P.B., Lee, J.-H., Boulware, D., Love, K., Abdulla, R., Roetzheim, R. (2009). Assessment of Elementary School Students¨ Sun Protection Behaviors. Pediatric Dermatology. [Epub ahead of print]
[11] Rollison, D., Helzlsouer, K., Lee, J.-H., Fulp, W., Clipp, S., Hoffman Bolton, J., Giuliano, A.R., Platz, E., and Viscidi, R. (2009). Prospective study of JC virus seroreactivity and the development of colorectal cancers and adenomas. Cancer Epidemiology, Biomarkers & Prevention 18, 1515-1523.
[12] Permuth-Wey, J., Boulware, D., Valkov, N., Livingston, S., Nicosia, S., Lee, J.-H., Sutphen, R., Schildkraut, J., Narod, S., Parker, A., Coppola, D., Sellers, T., and Pal, T. (2009). Sampling Strategies for Tissue Microarrays to evaluate biomarkers in Ovarian Cancer. Cancer Epidemiology, Biomarkers & Prevention 18, 28-34.
[13] Giuliano, A.R., Lazcano, E., Villa, L.L., Flores, R., Salmeron, J., Lee, J.-H., Papenfuss, M., Abrahamsen, M., Baggio, M.L., Silva, R., and Quiterio, M. (2009). Circumcision and Sexual Behavior: Factors Independently Associated with Human Paillomavirus (HPV) Detection Among Men in the HIM Study. International Journal of Cancer, 15, 1251-1257.
[14] Gwede, C.K., Menard, J.M., Martinez, D.D., Lee, J.-H., Vadaparampil, S.T., and Meade C.D (2009). Strategies to Assess Community Challenges and Strengths for Cancer Disparities Participatory Research and Outreach. Health Promotion Practice [Epub ahead of print]
[15] Daley, E.M., Buhi, E.R., Baldwin, J., Lee, J.-H., Vadaparampil, S.T., Abrahamsen, M., Vamos, C., Kolar, S., Chandler, R., Hesch, A.E., and Giuliano, A. (2009). Assessing Mens¨ Cognitive and Emotional Responses to an HPV Test Result: The Development of a Theory Driven Instrument, American Journal of Health Behavior 33, 728-744.
[16] Flores, R., Lu, B., Nielson, C., Abrahamsen, M., Wolf, K., Lee, J.-H., Harris, R.B., Giuliano, A.R. (2008). Correlated of Human Paillomavirus Viral Load with Infection Site in Asymptomatic Men. Cancer Epidemiology, Biomarkers & Prevention 17, 3573-3576.
[17] Giuliano, A.R., Lu, B., Nielson, C.M., Flores, R., Papenfuss, M., Lee, J.-H., Abrahamsen, M., and Harris, R.B. (2008). Age Specific Prevalence, Incidence, and Duration of Human Paillomavirus Infections among a Cohort of US Men. Journal of Infection Disease 198, 827-835.
[18] Giuliano, A.R., Lazcano, E., Villa, L.L., Flores, R. Salmeron, J., Lee, J.-H., Papenfuss, M., Abrahamsen, M., Jolles, E., Nielson, C., Baggio, I., and Silva, R. (2008). The Human Papillomavirus Infection in Men (HIM) Study: HPV Prevalence and Type-Distribution among Men Residing in Brazil, Mexico, and the U.S. Cancer Epidemiology, Biomarkers & Prevention 17, 2036-2043.
[19] Daud, A., Mirza, N., Lennox, B., Andrews, A., Urbas, P, Gao, G. X., Lee, J.-H., Sondak, V. K., Riker, A.I., Conti, R., and Gabrilovich, D. (2008). Phenotypic Analysis of Dendritic Cells and Clinical Outcome in Patients with High Risk Melanoma treated with Adjuvant GM-CSF. Journal of Clinic Oncology 26, 3235-3241.
[20] Cangiano, J., Centeno, B. A., Garrett, C. R., Caceres, W., Jesus A. D., Lee, J.-H., Pavia, O., Jove, R., Baez, L., Sullivan, D. M., Muro-Cacho, C. A., and Munoz-Antonia, T. (2008). Gastric Adenocarcinoma in Puerto Rican Hispanics and in Caucasians: Differences in Expression of Signal Transduction Proteins. Digestive Diseases and Sciences 53, 2090-2100.
[21] Clayton, H, Quinn, G.P., Lee, J.-H., King, L.M., Miree, C.A., Nieder, M., and Vadaparampil, S.T (2008). New Directions: Fertility Preservation for Pediatric Oncology Patients, Trends in Clinical Practice and Nurses¨ Attitudes. Oncology Nursing Forum 35, 249-255.
[22] Fishman, M., Hunter, T.B., Soliman, H., Thompson, P., Dunn, M., Smilee, R., Farmelo, M.J., Noyes, D.R., Mahany, J.J., Lee, J.-H., Cantor, A., Messina, J., Seigne, J., Pow-Sang, J., Janssen, W., and Antonia, S. (2007). Phase II Trial of B7-1 (CD-86) transduced, cultured autologous tumor cell vaccine plus subcutaneous interleukin-2 for treatment of stage IV renal cell carcinoma. Journal of Immunotherapy 31, 72-80.
[23] Fricke, I., Dupont J., Lockhart, C., Jackson, A., Lee, J.-H., LaFleur, B., Sosman, J. A., and Gabrilovich, D. I. (2007) Treatment of cancer patients with VEGF-Trap overcomes defects in DC differentiation but is insufficient to improve antigen-specific immune responses. Clinical Cancer Research 13, 4840-4848.
[24] Jacobsen, P., Shibata, D., Siegel, E., Mihaela, D., Lee, J.-H., Marshburn, J., Davenport, L. S., Cruse, H., Richard, L., Gondi, A., Brown, R., and Malafa, M. P.(2007). Measuring Quality of Care in the Treatment of Colorectal Cancer: The Moffitt Quality Practice Initiative, Journal of Oncology Practice 3, 60-65.
[25] Lee, J.-H., Eschrich, S., and Beam, C.A. (2007). An Exact Test for Detecting Inconsistency in Reader's Interpretation Over Time in Screening Mammograms. Biometrical Journal 49, 1-10. (Grant #: 1R03 EB0056401)
[26] Munster, P., Marchion, D., Bicaku, E., Schmitt, M., Lee, J.-H., DeConti, R., Simon, G., Fishman, M., Minton, S., Garrett, C., Chiappori, A., Lush, R., Sullivan, D., and Daud, A. (2007). Phase I Trial of Histone Deacetylase Inhibition by Valproic Acid (VPA) Followed by the Topoisomerase II Inhibitor Epirubicin in Advanced Solid Tumors: A Clinical and Translational Study, Journal of Clinic Oncology 25, 1979-1985.
[27] Lee, J.-H., Herzog, T.A., Meade, C.D., Webb, M.S., and Brandon, T.H. (2007). Use of GEE for Analyzing Longitudinal Binomial Data: A Primer Using Data from a Tobacco Intervention. Addictive Behaviors 32, 187 - 193.
[28] Park, J., Chen, L., Ratnashinge, L., Sellers, T.A., Tanner, J., Lee, J.-H., Dossett, N., Lang, N., Kadlubar, F.F., Ambrosone, C.B., Zachariah, B., Heysek, R.V., Paterson, S., and Pow-Sang, J. (2006). Deletion Polymorphism of UDP-Glucuronosyltransferase 2B17 and Risk of Prostate Cancer in African American and Caucasian Men. Cancer Epidemiology Biomarkers Prevention 15, 1473-1478.
[29] Chen, L., Ambrosone, C.B., Lee, J.-H., Sellers, T.A., Pow-Sang, J., and Park, J.Y. (2006). Association between polymorphisms in the DNA repair genes XRCC1 and APE1, and the Risk of Prostate Cancer in White and Black Americans. The Journal of Urology 175, 108-112.
[30] Antonia, S.J., Mirza, N., Fricke, I., Chiappori, A., Thompson, P., Williams, N., Belper, G., Simon, G., Janssen, W., Lee, J.-H., Menander, K., Chada, S., and Gabrilovich, D.I. (2006). Combination of p53 Cancer Vaccine with Chemotherapy in Patients with Extensive Stage Small Cell Lung Cancer. Clinical Cancer Research 12, 878-887.
[31] Fay, M.P. and Lee, J.-H. (2006). Measuring Agreement between Two Statistics with Applications to Age-Standardization. Journal of the Royal Statistical Society Series A 160, 1-16.
[32] Diaz, N., Minton, S.E., Cox, C., Bowman, T., Wloch, M., Livingston, S., Seijo, E., Cantor, A., Sullivan, D., Dalton, W.S., Beam, C.A., Lee, J.-H., Jove, R., and Muro-Cacho, C.A. (2006). Activation of Stat3 in Primary Tumors from High-Risk Breast Cancer Patients Is Associated with Elevated Levels of Activated Src and Survivin Expression. Clinical Cancer Research 12, 20-28.
[33] Gritsko, T., Williams, A., Turkson, J., Kaneko, S., Bowman, T., Huang, M., Nam, S., Eweis, I., Diaz, N., Sullivan, D., Yoder, S., Enkemann, S., Eschrich, S., Lee, J.-H., Beam, C.A., Cheng, J., Minton, S., Muro-Cacho, C.A., and Jove, R. (2006). Persistent Activation of Stat3 Signaling Induces Survivin Gene Expression and Confers Resistance to Apoptosis in Human Breast Cancer Cells. Clinical Cancer Research 12, 11-19.
[34] Nam, S., Kim, D., Cheng, J.Q., Zhang, S., Lee, J.-H., Buettner, R., Mirosevich, J., Lee, F.Y., and Jove, R. (2005). Action of the Src Family Knase Inhibitor, Dasatinib (BMS-354825), on Human Prostate Cancer Cells. Cancer Research Priority Reports 65, 9185-9189.
[35] Lee, J.-H. and Qaqish, B.F. (2005). A Latent Change Point Model Using a Generalized Estimating Equations Approach. Communication in Statistics—Theory and Methods 34, 1233-1242.
[36] Park, J., Chen, L., Lee, J.-H., Sellers, T., and Tockman, M. (2005). Polymorphisms in the Promoter Region of Neutrophil Elastase Gene and Lung Cancer Risk. Lung Cancer 48, 315-321.
[37] Hensing, T.A., Schell, M.J., Lee, J.-H., and Socinski, M.A. (2005). Factors associated with the likelihood of receiving second line therapy for advanced non-small cell lung cancer. Lung Cancer 47, 253-259.
[38] Lee, J.-H. and Qaqish, B.F. (2004). Modified GEE and Goodness-of-Marginal-Fit (GOMF) Tests with Correlated Binary Responses for Contingency Tables. Biometrical Journal 46, 675-686.
[39] Socinski, M.A., Neubauer, M.A., Olivares, J., Ketchel, S., Tynan, M., Moore, M., Lee, J.-H., Davis, K., Schell, M., and Garfield, D. (2003). Phase II Trial of Paclitaxel, Ifosfamide, and Carboplatin in Extensive-Stage Small Cell Lung Cancer. Lung Cancer 40, 91-97.
[40] Olivier, K., Weber, D.J., Lee, J.-H., Handler, A., Tudor, G., Molina, P., Tomashefski, J., and Knowles, M. (2003). Nontuberculous Mycobacteria in Cystic Fibrosis II: A Nested Cohort Study to Assess Impact on the Short-term Course of Lung Disease. American Journal of Respiratory and Critical Care Medicine 167, 835-840.
[41] Hensing, T.A., Peterman, A.H., Schell, M.J., Lee, J.-H., and Socinski, M.A. (2003). The Impact of Age on Toxicity, Response Rate, Quality of Life, and Survival in Patients with Advanced, Stage IIIB or IV Nonsmall Cell Lung Carcinoma Treated with Carboplatin and Paclitaxel. Cancer 98, 779-788.
[42] Olivier, K., Weber, D.J., Wallace, R.J., Faiz, A.R., Lee, J.-H., Zhang, Y., Brown-Elliot, B., Handler, A., Wilson, R., Schechter, M., Edwards, L., Chakraborti, S., and Knowles, M. (2003). Nontuberculous Mycobacteria in Cystic Fibrosis I: Multicenter Prevalence Study of a Potential Pathogen in a Susceptible Population. American Journal of Respiratory and Critical Care Medicine 167, 828-834.
[43] Socinski, M.A., Schell, M.J., Peterman, A., Bakri, K., Yates, S., Gitten, R., Unger, P., Lee, J., Lee, J.-H., Tynan, M., Moore, M., and Kies, M. (2002). Phase III Trial Comparing a Defined Duration of Therapy Versus Continuous Therapy Followed by Second-line Therapy in Advanced Stage IIIB/IV Non-small Cell Lung Cancer. Journal of Clinic Oncology 20, 1335-1343.
[44] Socinski, M.A., Schell, M.J., Bakri, K., Peterman, A., Lee, J.-H., Unger, P., Yates, S., Hudgens, S., and Kies, M.S. (2002). Second-line, Low-Dose, Weekly Paclitaxel in Patients with Stage IIIB/IV Nonsmall Cell Lung Carcinoma Who Fail First-line Chemotherapy with Carboplatin Plus Paclitaxel. Cancer 95, 1265-1273.